How has been the historical performance of Amrutanjan Healt?

Answer:The historical performance of Amrutanjan Healt shows a consistent growth trend in net sales and profits over the years leading up to March 2017.

Breakdown:
Amrutanjan Healt's net sales have increased from 140.41 Cr in March 2014 to 231.70 Cr in March 2017, demonstrating a strong upward trajectory. Other operating income has also seen growth, rising from 1.32 Cr in March 2014 to 2.88 Cr in March 2017, contributing to total operating income of 234.59 Cr in March 2017, up from 141.73 Cr in March 2014. The total expenditure, excluding depreciation, has increased from 120.02 Cr in March 2014 to 205.57 Cr in March 2017, reflecting higher costs in raw materials, employee expenses, and manufacturing. Despite rising costs, the operating profit (PBDIT) has shown resilience, reaching 33.85 Cr in March 2017 compared to 24.66 Cr in March 2014. Profit before tax has also improved, increasing from 19.38 Cr in March 2014 to 33.24 Cr in March 2017, while profit after tax rose from 12.44 Cr to 21.14 Cr in the same period. The earnings per share (EPS) have grown from 4.26 in March 2014 to 7.23 in March 2017, indicating enhanced shareholder value. Overall, Amrutanjan Healt has demonstrated a robust performance with increasing revenues and profits over the years.